top of page

Occuity partners with Ravita to Distribute PM1 Pachymeter in Ukraine

Richard Kadri-Langford

Occuity is pleased to announce Ravita Ltd as our exclusive distributor in Ukraine for the PM1 Pachymeter. This partnership will expand access to our non-contact ophthalmic technology, bringing advanced diagnostic solutions to more eye care professionals in the region.


With over 14 years of experience, Ravita is a well-established distributor of ophthalmic equipment, supplying optical shops, hospitals, and clinics across Ukraine. Their strong industry reputation and commitment to innovation make them an ideal partner for introducing Occuity’s PM1 Pachymeter and, in the future, the AX1 Axiometer™.

Mark Jenkins, COO of Occuity, commented:

“We’re delighted to welcome Ravita as our partner in Ukraine. They have been a pleasure to work with and their expertise and network will help bring our innovative technology to more clinicians, improving access to high-quality, non-invasive diagnostics.”

With CE certification secured, the PM1 Pachymeter is rolling out across Europe, providing fast, precise, and non-invasive corneal thickness measurements for glaucoma screening, refractive surgery, and corneal health assessments.


Oleksandr Duryshev, CEO of Ravita - demonstrating the Occuity PM1
Oleksandr Duryshev, CEO of Ravita - demonstrating the Occuity PM1

Oleksandr Duryshev, CEO of Ravita, added:

“We are delighted to partner with Occuity to bring their innovative devices to the Ukrainian market. It is clear that Occuity’s technology has the potential to transform how ophthalmic conditions are diagnosed and managed, and we look forward to contributing to this mission.”

This partnership is another step in Occuity’s international growth, ensuring more eye care professionals have access to the latest diagnostic innovations. As we continue to expand our product offerings, we are also preparing for the 2025 launch of the AX1 Axiometer™, a portable device designed for myopia management, further strengthening our commitment to advancing ophthalmic care.


For more information about the PM1 Pachymeter - please click here

 
 
 

Comments


bottom of page